Immunotherapy has great promise as a cancer treatment, but current therapies only work in some. Now, Stanford researchers are testing the idea that microorganisms in our guts might be the deciding factor.
In the third in a series on what the lives of Stanford researchers actually look like, chemists Noah Burns, Laura Dassama, Michael Fayer and Hemamala Karunadasa talk about their paths into the field, the joys of making new molecules and the way in which “the central science” pervades our lives.
Stanford engineers have developed experimental stickers that pick up physiological signals emanating from the skin, then wirelessly beam these health readings to a receiver clipped onto clothing. It’s all part of a system called BodyNet.
Stanford ChEM-H Institute Scholar Michael Fischbach explains why the microbiome is worth studying, the ways his lab hopes to advance our understanding of these complex communities, and how the people and mission of ChEM-H drew him to Stanford.
Stanford researchers have identified immune cells that help reduce the severity of a disease in mice akin to multiple sclerosis. These cells could one day be useful therapeutic targets in treating autoimmune diseases.